MX9805499A - Compuestos de azacicloheptano y diazacicloheptano y ciclooctano sustituidos y su uso. - Google Patents

Compuestos de azacicloheptano y diazacicloheptano y ciclooctano sustituidos y su uso.

Info

Publication number
MX9805499A
MX9805499A MX9805499A MX9805499A MX9805499A MX 9805499 A MX9805499 A MX 9805499A MX 9805499 A MX9805499 A MX 9805499A MX 9805499 A MX9805499 A MX 9805499A MX 9805499 A MX9805499 A MX 9805499A
Authority
MX
Mexico
Prior art keywords
diazacycloheptane
compounds
cyclooctane
substituted aza
aza
Prior art date
Application number
MX9805499A
Other languages
English (en)
Spanish (es)
Inventor
Hans-Joerg Treiber
Stefan Blank
Dorothea Starck
Liliane Unger
Hans-Juergen Teschendorf
Karsten Wicke
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of MX9805499A publication Critical patent/MX9805499A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
MX9805499A 1996-01-12 1998-07-07 Compuestos de azacicloheptano y diazacicloheptano y ciclooctano sustituidos y su uso. MX9805499A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19600934A DE19600934A1 (de) 1996-01-12 1996-01-12 Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung

Publications (1)

Publication Number Publication Date
MX9805499A true MX9805499A (es) 1998-11-30

Family

ID=7782613

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9805499A MX9805499A (es) 1996-01-12 1998-07-07 Compuestos de azacicloheptano y diazacicloheptano y ciclooctano sustituidos y su uso.

Country Status (26)

Country Link
US (2) US6214822B1 (enExample)
EP (1) EP0877744B1 (enExample)
JP (1) JP4349657B2 (enExample)
KR (1) KR100441073B1 (enExample)
CN (2) CN1075070C (enExample)
AR (1) AR005868A1 (enExample)
AT (1) ATE273301T1 (enExample)
AU (1) AU717726B2 (enExample)
BG (1) BG64098B1 (enExample)
CA (1) CA2241787C (enExample)
CO (1) CO4790173A1 (enExample)
CZ (1) CZ297981B6 (enExample)
DE (2) DE19600934A1 (enExample)
ES (1) ES2225947T3 (enExample)
HR (1) HRP970021A2 (enExample)
HU (1) HU228457B1 (enExample)
IL (1) IL125076A (enExample)
MX (1) MX9805499A (enExample)
NO (1) NO316753B1 (enExample)
NZ (1) NZ326332A (enExample)
PL (1) PL327692A1 (enExample)
SK (1) SK284987B6 (enExample)
TR (1) TR199801302T2 (enExample)
TW (1) TW475929B (enExample)
WO (1) WO1997025324A1 (enExample)
ZA (1) ZA97209B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19728996A1 (de) * 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
IL142388A0 (en) 1998-10-08 2002-03-10 Smithkline Beecham Plc Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
AR022230A1 (es) * 1999-01-12 2002-09-04 Abbott Gmbh & Co Kg Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para preparar dicha composicion
DE19922443A1 (de) 1999-05-07 2000-11-09 Basf Ag Verwendung von Dopamin-D3-Rezeptorliganden zur Herstellung von Arzneimittel für die Behandlung von Nierenfunktionsstörungen
US7037916B2 (en) 1999-07-15 2006-05-02 Pharmacopeia Drug Discovery, Inc. Pyrimidine derivatives as IL-8 receptor antagonists
DE50114170D1 (de) * 2000-03-27 2008-09-11 Abbott Gmbh & Co Kg Dopamin-d3-rezeptor-liganden zur behandlung von sucht
IL157413A0 (en) 2001-02-16 2004-03-28 Aventis Pharmaceuticals Inc Av Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
DE10109866A1 (de) * 2001-03-01 2002-09-05 Abbott Gmbh & Co Kg Triazolverbindungen und deren Verwendung zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie
DE10131543A1 (de) * 2001-06-29 2003-01-16 Abbott Lab Pyrimidinoxyalkylpiperazine und ihre therapeutische Verwendung
NZ533397A (en) * 2001-11-28 2005-12-23 Sod Conseils Rech Applic 5-sulphanyl-4H-1,2,4-triazole derivatives and their use as a medicament
CN1642422A (zh) * 2002-03-15 2005-07-20 西巴特殊化学品控股有限公司 4－氨基嘧啶及其在表面抗菌处理中的应用
DE10304870A1 (de) 2003-02-06 2004-08-19 Abbott Gmbh & Co. Kg Triazolverbindungen und ihre therapeutische Verwendung
TW200507841A (en) * 2003-03-27 2005-03-01 Glaxo Group Ltd Antibacterial agents
DE10358004A1 (de) * 2003-12-11 2005-07-14 Abbott Gmbh & Co. Kg Ketolactam-Verbindungen und ihre Verwendung
DE102004027358A1 (de) * 2004-06-04 2005-12-29 Abbott Gmbh & Co. Kg Pyrimidinverbindungen und ihre Verwendung
FR2877005A1 (fr) * 2004-10-22 2006-04-28 Bioprojet Soc Civ Ile Nouveaux derives d'arylpiperazine
US7511035B2 (en) * 2005-01-25 2009-03-31 Glaxo Group Limited Antibacterial agents
JP2007106746A (ja) * 2005-09-13 2007-04-26 Tosoh Corp 新規アリールホモピペラジン類、またはその塩と製造方法
JPWO2007099828A1 (ja) * 2006-02-23 2009-07-16 塩野義製薬株式会社 環式基で置換された含窒素複素環誘導体
US20070293548A1 (en) * 2006-03-31 2007-12-20 Wang Eric Y Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases
EP1882688A1 (en) * 2006-07-25 2008-01-30 EPFL Ecole Polytechnique Fédérale de Lausanne Labelling of fusion proteins with synthetic probes
JP4840440B2 (ja) * 2008-12-24 2011-12-21 ソニー株式会社 画像処理装置およびその方法、並びにプログラム
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
JP2013518046A (ja) * 2010-01-25 2013-05-20 シーエイチディーアイ ファウンデーション，インコーポレーテッド 特定のキヌレニン−３−モノオキシゲナーゼインヒビターおよびその医薬組成物ならびにこれらの使用方法
WO2012003418A2 (en) * 2010-07-02 2012-01-05 The University Of North Carolina At Chapel Hill Functionally selective ligands of dopamine d2 receptors
NZ610315A (en) 2010-11-15 2015-08-28 Univ Leuven Kath Antiviral condensed heterocyclic compounds
MX2014002459A (es) 2011-08-30 2014-04-10 Chdi Foundation Inc Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodos de uso de los mismos.
HRP20170928T1 (hr) 2011-08-30 2017-09-22 Chdi Foundation, Inc. Inhibitori kinurenin-3-monooksigenaze, farmaceutski pripravci, i postupci za njihovu upotrebu
EP3756666A1 (en) 2013-12-24 2020-12-30 Oncotartis Inc. Nicotinamide compound for use in the treatment of cancer
CR20170061A (es) 2014-07-17 2017-07-17 Chdi Foundation Inc Métodos y composiciones para el tratamiento de trastornos relacionados con vih

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE628766A (enExample) 1962-12-26
BE792206A (enExample) 1971-12-02 1973-06-01 Byk Gulden Lomberg Chem Fab
US5139998A (en) 1988-08-31 1992-08-18 Superconductor Technologies, Inc. Controlled thallous oxide evaporation for thallium superconductor films and reactor design
SE8803429D0 (sv) * 1988-09-28 1988-09-28 Pharmacia Ab Novel pyridyl- and pyrimidyl derivatives
US5008267A (en) 1988-10-29 1991-04-16 Mitsui Toatsu Chemicals, Incorporated Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same
JP2815218B2 (ja) 1990-04-13 1998-10-27 三井化学株式会社 ピリミジンジオン誘導体、およびそれを含有する抗不整脈剤
FR2663638B2 (fr) 1990-04-06 1995-02-10 Institut Nal Sante Recherc Medic Polypeptides ayant une activite de recepteur dopaminergique, acides nucleiques codant pour ces polypeptides et utilisation de ces polypeptides pour le criblage de substances actives sur ces polypeptides.
JP2518965B2 (ja) 1990-09-21 1996-07-31 三井東圧化学株式会社 新規ピリジン誘導体及びそれを有効成分として含有する制癌剤効果増強剤
FR2668771B1 (fr) 1990-11-06 1995-03-17 Inst Nat Sante Rech Med Acides nucleiques codant pour des polypeptides ayant une activite de recepteur dopaminergique humain et utilisation de ces polypeptides pour le criblage de substances actives sur ces polypeptides.
DE4425145A1 (de) 1994-07-15 1996-01-18 Basf Ag Verwendung von Thiazol- und Thiadiazolverbindungen
DE4425143A1 (de) 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
DE4425144A1 (de) 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
DE4425146A1 (de) 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
US5635503A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Company Dihydropyridine npy antagonists: piperazine derivatives
FR2742149B1 (fr) 1995-12-11 1998-02-13 Inst Nat Sante Rech Med Nouveaux derives de 2-naphtamides et leurs applications therapeutiques

Also Published As

Publication number Publication date
EP0877744B1 (de) 2004-08-11
IL125076A (en) 2001-05-20
HU228457B1 (en) 2013-03-28
TW475929B (en) 2002-02-11
BG64098B1 (bg) 2003-12-31
SK284987B6 (sk) 2006-04-06
CN1075070C (zh) 2001-11-21
WO1997025324A1 (de) 1997-07-17
ZA97209B (en) 1998-07-10
EP0877744A1 (de) 1998-11-18
AU1440797A (en) 1997-08-01
KR100441073B1 (ko) 2004-11-16
NO983187L (no) 1998-09-09
US6352981B1 (en) 2002-03-05
US6214822B1 (en) 2001-04-10
PL327692A1 (en) 1998-12-21
NO316753B1 (no) 2004-04-26
HUP9901590A2 (hu) 1999-08-30
SK94198A3 (en) 1999-03-12
AR005868A1 (es) 1999-07-21
KR19990077127A (ko) 1999-10-25
DE19600934A1 (de) 1997-07-17
HUP9901590A3 (en) 2002-01-28
DE59711847D1 (de) 2004-09-16
TR199801302T2 (xx) 1998-11-23
CA2241787C (en) 2006-04-04
CN1348956A (zh) 2002-05-15
ES2225947T3 (es) 2005-03-16
JP4349657B2 (ja) 2009-10-21
CZ215998A3 (cs) 1999-05-12
ATE273301T1 (de) 2004-08-15
CN1212692A (zh) 1999-03-31
NZ326332A (en) 1999-04-29
CN1146551C (zh) 2004-04-21
CA2241787A1 (en) 1997-07-17
IL125076A0 (en) 1999-01-26
HRP970021A2 (en) 1998-04-30
JP2000505072A (ja) 2000-04-25
AU717726B2 (en) 2000-03-30
BG102616A (en) 1999-04-30
CZ297981B6 (cs) 2007-05-16
CO4790173A1 (es) 1999-05-31

Similar Documents

Publication Publication Date Title
MX9805499A (es) Compuestos de azacicloheptano y diazacicloheptano y ciclooctano sustituidos y su uso.
MX9700430A (es) El uso de compuestos heterociclicos.
BG105783A (en) Triazole compounds with dopamine-d3-receptor affinity
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
TR200000009T2 (tr) Triazol bileşikleri ve bunların dopamin-D3-ligandları olarak kullanımları.
TR200200068T2 (tr) Nematisital triflüorobütenler
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
MY120511A (en) New pesticides
TR200003011T2 (tr) Yeni dihidropirimidinler.
GR3032161T3 (en) Amido siladiyl bridged catalyst components, methods of making and using
NO970162L (no) Substituerte pyrimidinforbindelser og anvendelse derav
CA2276455A1 (en) Phthalazinones
MX9603465A (es) N-pirazolilanilinas y n-pirazolilaminopiridinas como agentes pesticidas.
MXPA04004939A (es) 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3-alquilados y 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3,3??-dialquilados y procesos para su fabricacion.
TR199901282T2 (xx) Heterosiklik olarak ikame edilmi� yeni benzamitler.
YU2500A (sh) Alatrofloksacin parenteralni preparati
MY124078A (en) Eletriptan hydrobromide monohydrate
ES8500225A1 (es) Un procedimiento para preparar 3-fenoxi-1-azetidincarbo-xznmidas
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
PL343546A1 (en) Processes for preparing intermediates
PE20399A1 (es) Muteina ob
ZA983231B (en) Substituted benzyloxyimino compounds.
MX9603087A (es) Procedimiento para la obtencion de aminocarboniltriazolinonas substituidas.
CA1263656C (en) ARYLOXYCYCLOALCANOLAMINOALCOYLENE-ARYL-KETONES
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine